Rectal fistulae resulting from treatment with sorafenib and bevacizumab. [electronic resource]
Producer: 20100304Description: 1246-7 p. digitalISSN:- 1097-6779
- Angiogenesis Inhibitors -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- adverse effects
- Benzenesulfonates -- adverse effects
- Bevacizumab
- Female
- Humans
- Middle Aged
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Pyridines -- adverse effects
- Rectal Fistula -- chemically induced
- Sorafenib
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.